Literature DB >> 32556651

Clostridioides difficile infection in US hospitals: a national inpatient sample study.

Daryl Ramai1, Khoi Paul Dang-Ho2, Chris Lewis3, Paul J Fields3, Andrew Ofosu4, Mohamed Barakat4, Ali Aamar4, Emmanuel Ofori4, Jonathan Lai5, Gandhi Lanke6, Amaninder Dhaliwal7, Madhavi Reddy4, James Gasperino8.   

Abstract

BACKGROUND: Hypervirulent strains of Clostridioides difficile have altered the landscape of hospital and community outbreaks. We aim to examine and compare spatiotemporal trends, incidence, hospital teaching status, mortality, and cost associated with hospital-acquired Clostridioides difficile infection (HCDI) and community-acquired Clostridioides difficile infection (CCDI).
METHODS: Retrospective cohorts were studied using data from the Healthcare Cost and Utilization Project (HCUP) Nationwide Inpatient Sample (NIS) from 2006 to 2015.
RESULTS: A total of 76,124 cases of HCDI and 190,641 cases of CCDI were identified within the study period. The incidence of HCDI decreased from 8555 in 2006 to 7191 in 2015. Mortality also decreased during the same period (5.9% in 2006 to 1.4% 2015, p < 0.0001). Conversely, CCDI cases increased from 13,823 in 2006 to 20,637 in 2015. CCDI mortality decreased during the same period (4.3% in 2006 to 1.9% 2015, p < 0.0001). Rural hospital centers experienced the sharpest decline in HCDI mortality compared to urban and urban teaching centers (3.8%, p < 0.0001 vs 2.8%, p < 0.0001 vs 2.1%, p < 0.0001). Multivariate logistic regression indicated that increasing age (p = 0.0001), increasing hospital length of stay (p = 0.0001), and Medicare insurance (p = 0.002) were significant predictors of mortality for CDI mortality. Geospatial mapping of CCDI and HCDI revealed that the Eastern and Southern US experienced the largest incidence of CDI over 10 years.
CONCLUSION: The incidence of HCDI has decreased in the past decade while the incidence of CCDI hospitalization is sharply on the rise. While hospital length of stay and mortality has decreased over time, the cost of treating CDI remains high.

Entities:  

Keywords:  Clostridioides difficile; Community acquired clostridioides difficile infection (CCDI); Health care cost and utilization project (HCUP); Hospital-aquired clostridioides difficile infection (HCDI); National inpatient sample (NIS)

Mesh:

Year:  2020        PMID: 32556651     DOI: 10.1007/s00384-020-03646-3

Source DB:  PubMed          Journal:  Int J Colorectal Dis        ISSN: 0179-1958            Impact factor:   2.571


  16 in total

1.  Higher Incidence of Clostridium difficile Infection Among Individuals With Inflammatory Bowel Disease.

Authors:  Harminder Singh; Zoann Nugent; B Nancy Yu; Lisa M Lix; Laura E Targownik; Charles N Bernstein
Journal:  Gastroenterology       Date:  2017-05-04       Impact factor: 22.682

Review 2.  Risk factors for recurrent Clostridium difficile infection: a systematic review and meta-analysis.

Authors:  Abhishek Deshpande; Vinay Pasupuleti; Priyaleela Thota; Chaitanya Pant; David D K Rolston; Adrian V Hernandez; Curtis J Donskey; Thomas G Fraser
Journal:  Infect Control Hosp Epidemiol       Date:  2015-01-28       Impact factor: 3.254

3.  Cancer of the vagina.

Authors:  F Rutledge
Journal:  Am J Obstet Gynecol       Date:  1967-03-01       Impact factor: 8.661

4.  Favorable impact of a multidisciplinary antibiotic management program conducted during 7 years.

Authors:  Philip Carling; Teresa Fung; Ann Killion; Norma Terrin; Michael Barza
Journal:  Infect Control Hosp Epidemiol       Date:  2003-09       Impact factor: 3.254

Review 5.  Recurrent Clostridium difficile infection: a review of risk factors, treatments, and outcomes.

Authors:  Stuart Johnson
Journal:  J Infect       Date:  2009-04-05       Impact factor: 6.072

Review 6.  Antimicrobial resistance in Clostridium difficile.

Authors:  Haihui Huang; Andrej Weintraub; Hong Fang; Carl Erik Nord
Journal:  Int J Antimicrob Agents       Date:  2009-10-13       Impact factor: 5.283

7.  Increasing prevalence and severity of Clostridium difficile colitis in hospitalized patients in the United States.

Authors:  Rocco Ricciardi; David A Rothenberger; Robert D Madoff; Nancy N Baxter
Journal:  Arch Surg       Date:  2007-07

Review 8.  Community-acquired Clostridium difficile infection: an increasing public health threat.

Authors:  Arjun Gupta; Sahil Khanna
Journal:  Infect Drug Resist       Date:  2014-03-17       Impact factor: 4.003

Review 9.  Cost of hospital management of Clostridium difficile infection in United States-a meta-analysis and modelling study.

Authors:  Shanshan Zhang; Sarah Palazuelos-Munoz; Evelyn M Balsells; Harish Nair; Ayman Chit; Moe H Kyaw
Journal:  BMC Infect Dis       Date:  2016-08-25       Impact factor: 3.090

Review 10.  The Antimicrobial Stewardship Approach to Combating Clostridium Difficile.

Authors:  Eric Wenzler; Surafel G Mulugeta; Larry H Danziger
Journal:  Antibiotics (Basel)       Date:  2015-06-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.